Research Library · Muscle / GH-axis

IGF-1 LR3: What the Research Actually Shows

At a Glance

What it is: A lab-made version of IGF-1, edited in two spots so it lasts longer and slips past the proteins that hold IGF-1 in check.
Researchers have studied it for: growing engineered cells in lab culture, body weight and muscle in food-restricted and catabolic rats, and organ growth in guinea pigs.
Evidence level: There are no human trials. Its main documented use is as a lab cell-culture reagent, and the animal results are mixed.
The short version: LR3 IGF-1 has mostly been used as a research reagent for growing cells, not tested in people. The animal work is split, holding body weight in one model without saving muscle. There is no human data, and this is a research summary, not a reason to use anything.

IGF-1 LR3 (Long R3 IGF-1) is a lab-made version of IGF-1, changed in two spots so it lasts longer and slips past the proteins that normally hold IGF-1 in check. Most of its real-world use has been as a research reagent in cell culture, and the honest headline is that human data on it is thin, which this page does not hide.

Below is what researchers looked at, in what kind of model, and what they observed.

What researchers have studied

Its main real-world job, growing cells in a lab (industry cell-culture documentation). The most common documented use of Long R3 IGF-1 is as an additive put into cell cultures to help engineered cells grow and produce proteins like antibodies. Biopharma suppliers report it can raise output in CHO cells (a standard lab cell line) compared with insulin or no additive. This is manufacturing and lab-reagent data, not a study in animals or people, and it is industry documentation rather than peer-reviewed research. Source: Repligen LONG R3 IGF-I product materials. https://www.repligen.com/products/cell-culture-supplements/long-r3-igf-i

Food-restricted rats (Tomas, Growth Hormone and IGF Research, 2001). Rats on limited food received LR3 IGF-1 by infusion. It kept their overall body weight higher, but it did not protect their skeletal muscle from wasting. An honest split result: better body weight, no muscle rescue. Rat model, not people. PMID 11472075. https://pubmed.ncbi.nlm.nih.gov/11472075/

Catabolic rats (Tomas, Biochemical Journal, 1992). In rats pushed into tissue loss with a steroid (dexamethasone), LR3 IGF-1 was about 2.5 times more potent than regular IGF-1 at pushing back against the loss. Researchers linked that strength to the fact that the analog dodges the binding proteins. Rat model, catabolic state. PMID 1371669. https://pubmed.ncbi.nlm.nih.gov/1371669/

Organ growth in guinea pigs (Conlon, Journal of Endocrinology, 1995). A steady infusion of Long R3 IGF-1 grew certain organs (gut, kidney, spleen, and adrenal glands) but also lowered the animals’ own circulating IGF-1 and its binding proteins. It showed the analog acts on the body differently than natural IGF-1 does. Guinea pig model. PMID 7561636. https://pubmed.ncbi.nlm.nih.gov/7561636/

How it works

Start with the natural molecule. IGF-1 is 70 amino acids long, and in the blood it mostly rides on carrier proteins (IGF binding proteins) that grab it and release it slowly.

LR3 is that molecule with two edits. First, one building block at position 3 is swapped (glutamic acid becomes arginine, which is the “R3” in the name). Second, a 13-amino-acid tail is added to the front (the “Long” part). That makes it 83 amino acids instead of 70.

Those two changes make it bind the carrier proteins very weakly. So instead of being held and doled out slowly, more of it stays free to act, and researchers report it lasts longer, a window measured in hours rather than the short one natural IGF-1 has on its own. It still binds the same IGF-1 receptor and turns on the same build signal. That combination, same receptor plus longer free time, is the whole reason the analog exists as a research tool.

What the research does not establish

There is almost no human data. LR3 IGF-1 has been used mainly as a lab reagent, not tested as a treatment in people, and there are no human trials showing it is effective.
The animal results are mixed. In one model it held body weight but did not save muscle. It is not shown to build muscle, cut fat, or improve performance in humans.
LR3 IGF-1 sits under the same performance-enhancement and doping associations as IGF-1. The research does not establish that it improves performance in healthy people, and nothing on this page is usage guidance.
Nothing here is a safety conclusion. This is not a claim that the compound is safe to use.
It is not FDA-approved for any human use.

The thin human record is the point. Anyone telling you the human case is settled is well ahead of the research.

For Research Use Only. Not for human consumption. Etched Research supplies compounds for laboratory and research use only. Independent identity and purity testing by Janoshik. Nothing on this page is medical advice, a health claim, or a recommendation to use.